Literature DB >> 33819817

Reinforcement learning abnormalities in the attenuated psychosis syndrome and first episode psychosis.

Gregory P Strauss1, Raktima Datta2, William Armstrong2, Ian M Raugh3, Nina V Kraguljac2, Adrienne C Lahti2.   

Abstract

Prior studies indicate that chronic schizophrenia (SZ) is associated with a specific profile of reinforcement learning abnormalities. These impairments are characterized by: 1) reductions in learning rate, and 2) impaired Go learning and intact NoGo learning. Furthermore, each of these deficits are associated with greater severity of negative symptoms, consistent with theoretical perspectives positing that avolition and anhedonia are associated with impaired value representation. However, it is unclear whether these deficits extend to earlier phases of psychotic illness and when individuals are unmedicated. Two studies were conducted to examine reinforcement learning deficits in earlier phases of psychosis and in high risk patients. In study 1, participants included 35 participants with first episode psychosis (FEP) with limited antipsychotic medication exposure and 25 healthy controls (HC). Study 2 included 17 antipsychotic naïve individuals who were at clinical high-risk for psychosis (CHR) (i.e., attenuated psychosis syndrome) and 18 matched healthy controls (HC). In both studies, participants completed the Temporal Utility Integration Task, a measure of probabilistic reinforcement learning that contained Go and NoGo learning blocks. FEP displayed impaired Go and NoGo learning. In contrast, CHR did not display impairments in Go or NoGo learning. Impaired Go learning was not significantly associated with clinical outcomes in the CHR or FEP samples. Findings provide new evidence for areas of spared and impaired reinforcement learning in early phases of psychosis.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Clinical high-risk; Early psychosis; Psychosis risk; Reward learning; Ultra high-risk

Mesh:

Substances:

Year:  2021        PMID: 33819817      PMCID: PMC8197752          DOI: 10.1016/j.euroneuro.2021.03.014

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   5.415


  45 in total

1.  Expected value and prediction error abnormalities in depression and schizophrenia.

Authors:  Victoria B Gradin; Poornima Kumar; Gordon Waiter; Trevor Ahearn; Catriona Stickle; Marteen Milders; Ian Reid; Jeremy Hall; J Douglas Steele
Journal:  Brain       Date:  2011-04-10       Impact factor: 13.501

2.  Probabilistic Category Learning and Striatal Functional Activation in Psychosis Risk.

Authors:  Nicole R Karcher; Jessica P Y Hua; John G Kerns
Journal:  Schizophr Bull       Date:  2019-03-07       Impact factor: 9.306

3.  Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia.

Authors:  Gregory P Strauss; Michael J Frank; James A Waltz; Zuzana Kasanova; Ellen S Herbener; James M Gold
Journal:  Biol Psychiatry       Date:  2010-12-17       Impact factor: 13.382

4.  Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia.

Authors:  H Häfner; W Löffler; K Maurer; M Hambrecht; W an der Heiden
Journal:  Acta Psychiatr Scand       Date:  1999-08       Impact factor: 6.392

Review 5.  The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.

Authors:  Ann M Kring; Deanna M Barch
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 4.600

6.  Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study.

Authors:  Gregory P Strauss; Martin Harrow; Linda S Grossman; Cherise Rosen
Journal:  Schizophr Bull       Date:  2008-12-18       Impact factor: 9.306

7.  Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia.

Authors:  Barbara A Cornblatt; Andrea M Auther; Tara Niendam; Christopher W Smith; Jamie Zinberg; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2007-04-17       Impact factor: 9.306

Review 8.  A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.

Authors:  Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

9.  A role for dopamine in temporal decision making and reward maximization in parkinsonism.

Authors:  Ahmed A Moustafa; Michael X Cohen; Scott J Sherman; Michael J Frank
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

10.  Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials.

Authors:  Paolo Fusar-Poli; Evangelos Papanastasiou; Daniel Stahl; Matteo Rocchetti; William Carpenter; Sukhwinder Shergill; Philip McGuire
Journal:  Schizophr Bull       Date:  2014-12-20       Impact factor: 9.306

View more
  2 in total

1.  Relationships between self-reflectiveness and clinical symptoms in individuals during pre-morbid and early clinical stages of psychosis.

Authors:  Lihua Xu; Huiru Cui; Yanyan Wei; Zhenying Qian; Xiaochen Tang; Yegang Hu; Yingchan Wang; Hao Hu; Qian Guo; Yingying Tang; Tianhong Zhang; Jijun Wang
Journal:  Gen Psychiatr       Date:  2022-05-31

2.  The Role of Dopaminergic Genes in Probabilistic Reinforcement Learning in Schizophrenia Spectrum Disorders.

Authors:  Dorota Frydecka; Błażej Misiak; Patryk Piotrowski; Tomasz Bielawski; Edyta Pawlak; Ewa Kłosińska; Maja Krefft; Kamila Al Noaimy; Joanna Rymaszewska; Ahmed A Moustafa; Jarosław Drapała
Journal:  Brain Sci       Date:  2021-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.